Interferon-e as potential inhibitor of Chlamydia trachomatis infection

被引:1
|
作者
Filardo, Simone [1 ]
Di Pietro, Marisa [1 ]
Bozzuto, Giuseppina [2 ]
Fracella, Matteo [3 ]
Bitossi, Camilla [3 ]
Molinari, Agnese [2 ]
Scagnolari, Carolina [3 ]
Antonelli, Guido [3 ]
Sessa, Rosa [1 ]
机构
[1] Sapienza Univ, Dept Publ Hlth & Infect Dis, Sect Microbiol, Ple Aldo Moro 5, I-00185 Rome, Italy
[2] Italian Natl Inst Hlth, Natl Ctr Drug Res & Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy
[3] Sapienza Univ, Fdn Cenci Bolognetti, Lab Ist Pasteur Italia, Dept Mol Med,Lab Virol, Viale Porta Tiburtina 28, I-00185 Rome, Italy
关键词
Chlamydia trachomatis; Genital infections; Interferon-e; Anti-bacterial activity; GENITAL-TRACT INFECTION; EPSILON; IFN; IMMUNITY; CELLS;
D O I
10.1016/j.micpath.2023.106427
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chlamydia trachomatis, the main cause of bacterial sexually transmitted diseases, is responsible for severe reproductive sequelae. Amongst all the cytokines involved in host immunity towards this pathogen, IFN-e has recently acquired importance for its potential contribution to the female reproductive tract innate defenses. Herein, our study aimed to explore, for the first time, the activity of IFN-e toward C. trachomatis in an in vitro infection model, by testing its effects on the different phases of chlamydial developmental cycle, as well as on the ultrastructural characteristics of chlamydial inclusions, via transmission electron microscopy. Main result is the capability of IFN-e to alter C. trachomatis growth, as suggested by reduced infectious progenies, as well as a patchy distribution of bacteria and altered morphology of reticulate bodies within inclusions. In conclusion, our results suggest that IFN-e could play a role in the innate and adaptive immune defenses against C. trachomatis; in the future, it will be needed to investigate its activity on an infection model more closely resembling the physiological environment of the female genital tract.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] CERVICAL CYTOLOGY AND CHLAMYDIA TRACHOMATIS INFECTION
    BOON, ME
    HOGEWONING, CJA
    TJIAM, KH
    MEIJER, CJLM
    LINDEMAN, J
    RUINAARD, C
    KIEVITTYSON, PA
    ARCHIVES OF GYNECOLOGY, 1983, 233 (02): : 131 - 140
  • [42] SCREENING FOR CHLAMYDIA-TRACHOMATIS INFECTION
    SKOLNIK, NS
    AMERICAN FAMILY PHYSICIAN, 1995, 51 (04) : 821 - 826
  • [43] Chlamydia trachomatis infection in an urban setting
    Mania-Pramanik, J
    Meherji, PK
    Gokral, JS
    Donde, UM
    SEXUALLY TRANSMITTED INFECTIONS, 2001, 77 (02) : 141 - 141
  • [44] CHLAMYDIA TRACHOMATIS IN WOMEN - CHRONIC INFECTION
    MCCORMACK, WM
    ALPERT, S
    NICHOLS, RL
    MCCOMB, DE
    CLINICAL RESEARCH, 1977, 25 (03): : A381 - A381
  • [45] RE: Sampling for Chlamydia trachomatis infection
    Falk, L.
    Fredlund, H.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (12) : 847 - 847
  • [46] CHLAMYDIA-TRACHOMATIS INFECTION AND ADOLESCENTS
    HENRYSUCHET, J
    CONTRACEPTION FERTILITE SEXUALITE, 1995, 23 (05): : 323 - 326
  • [47] Diagnosis and treatment of Chlamydia trachomatis infection
    Miller, KE
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (08) : 1411 - 1416
  • [48] Detecting Chlamydia trachomatis infection in women
    Joshi, J
    ACTA CYTOLOGICA, 2001, 45 (05) : 890 - 891
  • [49] WOMEN WITH CHLAMYDIA-TRACHOMATIS INFECTION
    COX, RA
    CRICK, M
    BRITISH MEDICAL JOURNAL, 1989, 299 (6714): : 1527 - 1527
  • [50] Treatment and prevention of Chlamydia trachomatis infection
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2022, 61 (620): : 12 - 14